Sofosbuvir/velpatasvir/voxilaprevir: Phase III data

Top-line data from the open-label, international Phase III POLARIS-4 trial in 333 patients with chronic HCV genotypes 1-4 infection who failed prior treatment with a direct-acting antiviral (DAA) that...